Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Autor: Pulczynski EJ; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning., Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg., Kuittinen O; Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio., Fagerli UM; Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway., Erlanson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Fluge Ø; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Leppä S; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki., Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway., Eriksson M; Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden., El-Galaly T; Department of Hematology, Aalborg University Hospital, Aalborg., Kuitunen H; Cancer Centre, Oulu University Hospital, Oulu., Papworth K; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Ljungqvist M; Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden., Pedersen MB; Department of Haematology, Aarhus University Hospital, Aarhus., Pollari M; Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.
Jazyk: angličtina
Zdroj: Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2359-2363. Date of Electronic Publication: 2024 Jul 01.
DOI: 10.3324/haematol.2024.285207
Databáze: MEDLINE